Chapter 170 Fever without a Focus
Fever without Localizing Signs
Fever of acute onset, with duration of <1 wk and without localizing signs, is a common diagnostic dilemma in children <36 mo of age. The etiology and evaluation of fever without localizing signs depends on the age of the child. Traditionally, 3 age groups are considered: neonates or infants to 1 mo of age, infants >1 mo to 3 mo of age, and children >3 mo to 3 yr of age. In 1993, practice guidelines were published to aid the clinician in evaluating the otherwise healthy 0 to 36 mo old with fever without a source. However, with the advent and extensive use of the conjugate Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae vaccines, the rates of infections with these 2 pathogens have decreased substantially. As a consequence, modifications to the 1993 guidelines have been advocated as described later. Children in high-risk groups (Table 170-1) require a more-aggressive approach and consideration of a broader differential diagnosis.
RISK GROUP | DIAGNOSTIC CONSIDERATIONS |
---|---|
IMMUNOCOMPETENT PATIENTS | |
Neonates (<28 days) | Sepsis and meningitis caused by group B streptococcus, Escherichia coli, Listeria monocytogenes; neonatal herpes simplex virus infection, enteroviruses |
Infants 1-3 mo | Serious bacterial disease in 10-15%, including bacteremia in 5%; urinary tract infection |
Infants and children 3-36 mo | Occult bacteremia in <0.5% of children immunized with both Haemophilus influenzae type b and pneumococcal conjugate vaccines; urinary tract infections |
Hyperpyrexia (>40°C) | Meningitis, bacteremia, pneumonia, heatstroke, hemorrhagic shock-encephalopathy syndrome |
Fever with petechiae | Bacteremia and meningitis caused by Neisseria meningitidis, H. influenzae type b, and Streptococcus pneumoniae |
IMMUNOCOMPROMISED PATIENTS | |
Sickle cell disease | Sepsis, pneumonia, and meningitis caused by S. pneumoniae, osteomyelitis caused by Salmonella and Staphylococcus aureus |
Asplenia | Bacteremia and meningitis caused by N. meningitidis, H. influenzae type b, and S. pneumoniae |
Complement or properdin deficiency | Sepsis caused by N. meningitidis |
Agammaglobulinemia | Bacteremia, sinopulmonary infections |
AIDS | S. pneumoniae, H. influenzae type b, and Salmonella infections |
Congenital heart disease | Infective endocarditis; brain abscess with right-to-left shunting |
Central venous line | Staphylococcus aureus, coagulase-negative staphylococci, Candida |
Malignancy | Bacteremia with gram-negative enteric bacteria, S. aureus, and coagulase-negative staphylococci; fungemia with Candida and Aspergillus |
1 Month to 3 Months
Many academic institutions have investigated the optimal management of low-risk patients in this age group with fever without a focus (Table 170-2). The use of viral diagnostic studies (enteroviruses, respiratory viruses, rotavirus, and herpesvirus) in combination with the Rochester Criteria or similar criteria can enhance the ability to determine which infants are at high risk for serious bacterial infections (see Table 170-2). Febrile infants in whom a virus has been detected are at low or no risk of a serious bacterial infection. Well-appearing infants 1-3 mo of age can be managed safely using low-risk laboratory and clinical criteria as indicated in Table 170-2 if reliable parents are involved and close follow-up is assured.
Table 170-2 LOW RISK CRITERIA IN 1-3 MONTHS OLD WITH FEVER
BOSTON CRITERIA
Infants are at low risk if they appear well, have normal physical examination, have a caretaker reachable by telephone, and laboratory tests are as follows:
PHILADELPHIA PROTOCOL
Infants are at low risk if they appear well, have a normal physical examination, and laboratory tests are as follows:
PITTSBURGH GUIDELINES
Infants are at low risk if they appear well, have a normal physical examination, and laboratory tests are as follows:
ROCHESTER CRITERIA
Infants are at low risk if they appear well, have a normal physical examination, and laboratory findings are as follows:
CBC, complete blood count; CSF, cerebrospinal fluid; HPF, high-powered field; RBC, red blood cell; WBC: white blood cell.
3 Months to 36 Months of Age
Treatment of toxic-appearing febrile children 3-36 mo of age who do not have focal signs of infection includes hospitalization and prompt institution of antimicrobial therapy after specimens of blood, urine, and CSF are obtained for culture. Consensus practice guidelines published in 1993 recommended that children 3-36 mo of age who have a temperature of <39°C and do not appear toxic be observed as outpatients without performing diagnostic tests or administering antimicrobial agents. For nontoxic-appearing infants with a rectal temperature of ≥39°C, options include obtaining a blood culture and administering empirical antibiotic therapy (ceftriaxone, a single dose of 50 mg/kg, not to exceed 1 g); if the WBC count is >15,000/µL, obtaining a blood culture and beginning empirical antibiotic therapy; or obtaining a blood culture and observing as outpatients without empirical antibiotic therapy, with return for re-evaluation within 24 hr. Guidelines for managing febrile children 3-36 mo of age who have received both Hib and S. pneumoniae conjugate vaccines have not been established, but careful observation without empirical administration of antibiotic therapy is generally prudent. Because fully vaccinated young children are at a much lower risk of occult bacteremia and meningitis as the cause of acute fever without localizing signs, some advocate that the only laboratory tests needed in this age group when temperature is >39°C are a urinalysis and urine culture for circumcised boys <6 mo of age and uncircumcised boys and all girls <24 mo of age. Regardless of the management option (Table 170-3), the family should be instructed to return immediately if the child’s condition deteriorates or new symptoms develop.
GROUP | MANAGEMENT |
---|---|
Any toxic-appearing child 0-36 mo and temperature ≥38°C | Hospitalize, broad cultures plus other tests,* parenteral antibiotics |
Child <1 mo and temperature ≥38°C | Hospitalize, broad cultures plus other tests,* parenteral antibiotics |
Child 1-3 mo and temperature ≥38°C | Two-step process
Get Clinical Tree app for offline access
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical Tree |